1. Home
  2. RGNX vs AIRS Comparison

RGNX vs AIRS Comparison

Compare RGNX & AIRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGNX
  • AIRS
  • Stock Information
  • Founded
  • RGNX 2008
  • AIRS 2012
  • Country
  • RGNX United States
  • AIRS United States
  • Employees
  • RGNX N/A
  • AIRS N/A
  • Industry
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • AIRS Medical/Nursing Services
  • Sector
  • RGNX Health Care
  • AIRS Health Care
  • Exchange
  • RGNX Nasdaq
  • AIRS Nasdaq
  • Market Cap
  • RGNX 387.0M
  • AIRS 333.7M
  • IPO Year
  • RGNX 2015
  • AIRS 2021
  • Fundamental
  • Price
  • RGNX $6.76
  • AIRS $2.15
  • Analyst Decision
  • RGNX Strong Buy
  • AIRS Hold
  • Analyst Count
  • RGNX 9
  • AIRS 3
  • Target Price
  • RGNX $32.89
  • AIRS $3.75
  • AVG Volume (30 Days)
  • RGNX 1.0M
  • AIRS 374.4K
  • Earning Date
  • RGNX 05-07-2025
  • AIRS 03-14-2025
  • Dividend Yield
  • RGNX N/A
  • AIRS N/A
  • EPS Growth
  • RGNX N/A
  • AIRS N/A
  • EPS
  • RGNX N/A
  • AIRS N/A
  • Revenue
  • RGNX $83,328,000.00
  • AIRS $180,350,000.00
  • Revenue This Year
  • RGNX $285.14
  • AIRS N/A
  • Revenue Next Year
  • RGNX N/A
  • AIRS $5.63
  • P/E Ratio
  • RGNX N/A
  • AIRS N/A
  • Revenue Growth
  • RGNX N/A
  • AIRS N/A
  • 52 Week Low
  • RGNX $5.62
  • AIRS $2.05
  • 52 Week High
  • RGNX $21.19
  • AIRS $9.20
  • Technical
  • Relative Strength Index (RSI)
  • RGNX 41.59
  • AIRS 25.18
  • Support Level
  • RGNX $7.96
  • AIRS $2.58
  • Resistance Level
  • RGNX $8.35
  • AIRS $2.91
  • Average True Range (ATR)
  • RGNX 0.65
  • AIRS 0.32
  • MACD
  • RGNX -0.04
  • AIRS 0.01
  • Stochastic Oscillator
  • RGNX 13.21
  • AIRS 7.87

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

About AIRS AirSculpt Technologies Inc.

AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. At Elite Body Sculpture, company provide custom body contouring using proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure.

Share on Social Networks: